
Imunon
(NASDAQ) IMNN
Imunon Financials at a Glance
Market Cap
$7.56M
Revenue (TTM)
$0.00
Net Income (TTM)
-$14.64M
EPS (TTM)
-$5.17
P/E Ratio
-0.35
Dividend
$0.00
Beta (Volatility)
0.79 (Low)
Dividend
$0.00
Beta (Volatility)
0.79 (Low)
Price
$1.78
Volume
93,781
Open
$1.87
Price
$1.78
Volume
93,781
Open
$1.87
Previous Close
$1.78
Daily Range
$1.73 - $1.92
52-Week Range
$1.70 - $10.69
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
0.79 (Low)
Price
$1.78
Volume
93,781
Open
$1.87
Previous Close
$1.78
Daily Range
$1.73 - $1.92
52-Week Range
$1.70 - $10.69
Estimated Earnings Date
Aug 4, 2026
IMNN News

3 Biotech Stocks To Avoid
A Fool Looks Back
The Fool Looks Ahead
This Week in Biotech
Why Celsion Shares Were Eviscerated
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Imunon
Industry
Biotechnology
Sector
Health CareEmployees
20
CEO
Stacy R. Lindborg, PhD
Website
imunon.comHeadquarters
Lawrenceville, NJ 08648, US
IMNN Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-341.23%
Return on Capital
-181.55%
Return on Assets
-182.59%
Earnings Yield
-2.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.56M
Shares Outstanding
4.20M
Volume
93.78K
Avg. Volume
51.97K
Financials (TTM)
Gross Profit
-$331.22K
Operating Income
-$14.81M
EBITDA
-$13.97M
Operating Cash Flow
-$15.03M
Capital Expenditure
-$20.92K
Free Cash Flow
-$15.06M
Cash & ST Invst.
$4.79M
Total Debt
$911.75K
Imunon Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$166.54K
+92.3%
Gross Margin
0.00%
N/A
Market Cap
$7.56M
N/A
Market Cap/Employee
$302.55K
N/A
Employees
25
N/A
Net Income
-$4.25M
-3.6%
EBITDA
-$4.08M
-1.2%
Quarterly Fundamentals
Total Cash
$4.79M
+66.9%
Total Debt
$911.75K
-9.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$492.85K
-19.6%
Short Term Debt
$418.90K
+6.1%
Return on Assets
-1.83%
N/A
Return on Invested Capital
-3.84%
N/A
Free Cash Flow
-$3.99M
-28.3%
Operating Cash Flow
-$3.99M
-40.0%